Let me introduce you to Sarah.
She's 45, has tried every diet going, moves her body regularly, and still can't shift the weight. After her second child, something shifted metabolically — and it had nothing to do with her willpower. A recent visit to her doctor finally gave her an answer: insulin resistance. Her body has essentially stopped listening to insulin's signals, blood sugar is quietly creeping up, and no amount of clean eating is cutting through the noise.
Sound familiar? You're not alone — and you're not broken.
Why everyone is suddenly talking about GLP-1s
GLP-1 receptor agonists — think Ozempic, Wegovy, Mounjaro — are having a moment, and honestly? The science backs up some of the hype. These medications work on multiple levels at once: they signal insulin release when blood sugar rises, slow digestion so you stay fuller longer, and communicate directly with the brain to reduce appetite. The results in clinical trials have been genuinely striking — better blood sugar control, and for many people, significant weight loss that diet and exercise alone hadn't been able to deliver.
If you're living with type 2 diabetes, insulin resistance, prediabetes, or weight-related conditions like high blood pressure or fatty liver — this class of medication was essentially designed with you in mind.
The PCOS connection nobody is talking about loudly enough
Here's something that deserves way more attention: GLP-1 medications are showing real promise for women with polycystic ovary syndrome — and it makes complete biological sense.
PCOS and insulin resistance are deeply intertwined. Up to 70% of women with PCOS have some degree of insulin resistance, and that insulin dysfunction is often what's driving the most frustrating symptoms — the weight that won't move, the irregular cycles, the androgen-related issues like acne and excess hair growth. When insulin resistance improves, the downstream effects can be significant.
Early research and clinical experience are showing that GLP-1s may help regulate menstrual cycles, reduce androgen levels, and improve metabolic markers in women with PCOS — not just as a side effect of weight loss, but potentially through the direct impact on insulin signalling itself. For women who have spent years being told to "just lose weight" without being given the tools to actually do it, this is genuinely significant.
It's an emerging area — the studies are still catching up to the clinical reality — but if you have PCOS and have been struggling with insulin resistance, this is absolutely a conversation worth having with your doctor.
But first — do you actually know your numbers?
Before the medication conversation happens, you need the full picture. Here's what's worth asking your doctor about:
Fasting blood glucose — often the first number that starts telling a story
Hemoglobin A1c — the 2-3 month average that reveals patterns, not just snapshots
Oral glucose tolerance test (OGTT) — shows in real time how your body handles sugar
Fasting insulin levels — frequently skipped, but one of the most revealing pieces of the puzzle
And if you really want to understand what's happening in your body day-to-day? A continuous glucose monitor (CGM) is the tool having its own cultural moment right now — and for good reason. These small wearable devices track your blood sugar around the clock, showing you exactly how your meals, stress levels, sleep, and movement affect your glucose in real time. No guessing. No waiting for lab results. Just your body, telling you its own story.
For someone like Sarah, seeing that data was the turning point. Not a prescription — information.
Here's what the conversation needs to include
GLP-1 medications can be a powerful tool — and if you're on one, or considering one, that's a completely valid, evidence-informed choice. No shame in that.
And at the same time, it's worth knowing what we know and what we don't yet.
Most of the big clinical trials ran for one to two years. Long-term data — we're talking a decade-plus — is still catching up. There are real conversations happening in the medical community right now about muscle mass loss alongside fat loss, what happens to metabolism post-medication, and weight regain in people who discontinue. Questions around thyroid risk and pancreatitis are still being studied.
None of this is a reason to panic. It is a reason to be informed.
The most powerful version of this journey — whether you're on a GLP-1 or exploring whether it's right for you — is one where the medication is part of a bigger picture. Nutrition that supports muscle retention. Lifestyle habits that address the root drivers of insulin resistance. A healthcare team that's looking at the whole you, not just the prescription pad.
GLP-1s can open a door that felt firmly shut. What you do once you're through it still matters.
If you see yourself in Sarah's story — or in the millions of women navigating PCOS and insulin resistance without answers — start with the testing, get curious about your data, and ask your doctor the questions that go beyond the headline results. The full picture is always more interesting — and more empowering — than the highlight reel.












